Oxford American Handbook of Oncology

Gary H Lyman: Co-Director, Hutchinson Institute for Cancer Outcomes Research; Affiliate Professor, University of Washington Schools of Public Health and Pharmacy, Seattle, WA

Part 1 Background ; 1 Molecular cancer biology ; 2 Etiology and epidemiology ; Part 2 Cancer prevention and screening ; 3 Cancer prevention ; 4 Cancer screening ; 5 Genetic screening ; Part 3 Principles of management ; 6 Principles of cancer treatment ; 7 Surgical oncology ; 8 Principles of radiation oncology ; 9 Principles of chemotherapy ; 10 Hematopoietic stem cell transplantation ; 11 Hormone therapy ; 12 Targeted therapies ; 13 Gene therapy and immunotherapy for cancer ; 14 Complementary and alternative medicine ; 15 Clinical trials ; Part 4 Complications and supportive care ; 16 Anemia and fatigue ; 17 Febrile neutropenia ; 18 Pain management ; 19 Venous thromboembolism ; 20 Metabolic emergencies ; 21 Paraneoplastic syndromes ; 22 Superior vena cava syndrome and raised intracranial pressure ; 23 Spinal cord compression ; 24 Other obstructive complications ; 25 Late effects of cancer treatment ; 26 End-of-life care ; Part 5 Specific cancers ; 27 Thoracic cancers ; 28 Breast cancer ; 29 Gastrointestinal cancer I: esophagus, stomach, small intestine, carcinoid ; 30 Gastrointestinal cancer II: pancreas, biliary tract, hepatocellular ; 31 Gastrointestinal cancer III: colorectal, anus ; 32 Endocrine cancers ; 33 Genitourinary cancer I: renal, bladder, ureter, penile carcinomas ; 34 Genitourinary cancer II: prostate cancer ; 35 Genitourinary cancer III: testicular cancer ; 36 Gynecological cancer ; 37 Tumors of the central nervous system ; 38 Head and neck cancers ; 39 Cutaneous malignancies ; 40 Soft tissue and bone sarcomas ; 41 Acute leukemia ; 42 Chronic leukemias and myelodysplastic syndromes ; 43 Multiple myeloma ; 44 Malignant lymphoma ; 45 Cancer of unknown primary (CUP) ; Appendix